Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler (Early GRAFD)

NCT05284474 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT05284474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05284474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler (Early GRAFD)
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 3, 2024
Completion date
December 30, 2026
Enrollment
340 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth retardation, placenta diseases, preeclampsia